Position in PFE
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$565,181
-$109,300 QoQ
Shares Held
23,471
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#1,672
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. PFE ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
This page
|
23,471 | $565,181 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $565,181 | 23,471 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $674,481 | 24,020 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $763,683 | 30,670 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $808,149 | 31,717 | Shares | Sole | 2025-11-21 | |
| 2025-06-30 | $814,027 | 33,582 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $876,865 | 34,604 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $890,585 | 33,569 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $999,240 | 34,528 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $957,811 | 34,232 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $946,608 | 34,112 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $389,960 | 13,545 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $481,329 | 14,511 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $452,667 | 12,341 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $544,353 | 13,342 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $701,116 | 13,683 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $683,006 | 15,608 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $754,992 | 14,400 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $872,117 | 16,846 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,278,727 | 21,655 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,046,605 | 24,334 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,030,691 | 26,320 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $945,095 | 26,086 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,073,121 | 29,153 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,086,942 | 29,617 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $975,572 | 29,834 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $806,076 | 24,696 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||